» Articles » PMID: 31769407

Causes of Death Among Persons Affected by Leprosy in Korea, 2010-2013

Overview
Specialty Tropical Medicine
Date 2019 Nov 27
PMID 31769407
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In addition to the complications of leprosy, people affected by leprosy (PALs) can suffer from chronic diseases. We evaluated the recent pattern of deaths among Korean PALs and compared it with that in the general population. We analyzed the death certificate data of 1,359 PALs from 2010 through 2013. The all-cause and cause-specific standardized mortality ratio (SMR) and standardized mortality with 95% CI were calculated. Malignancy had the highest standardized mortality, with 130.9 deaths per 100,000 persons, followed by cardiovascular diseases (CVDs; 85.5 deaths) and respiratory diseases (38.2 deaths). Of malignancies, liver cancer caused the greatest number of cancer deaths (40.0 deaths). The all-cause mortality of PALs was significantly lower than that in the general population, corresponding to an SMR of 0.84 (95% CI 0.79-0.88). Deaths from malignancy and CVDs were significantly lower, corresponding to SMRs (95% CIs) of 0.88 (0.79-0.98) and 0.75 (0.67-0.84), respectively. The death rates for lung and stomach cancers were lower, whereas mortality due to liver cancer was higher, with an SMR of 1.79 (95% CI 1.43-2.22). Except for liver cancer and infection, the causes of mortality of PALs tend to be lower than that in the general population. The most common underlying cause of death in PALs was stroke, followed by ischemic heart disease, liver cancer, and pneumonia.

Citing Articles

Global patterns of syphilis, gonococcal infection, typhoid fever, paratyphoid fever, diphtheria, pertussis, tetanus, and leprosy from 1990 to 2021: findings from the Global Burden of Disease Study 2021.

Chen W, Chen Y, Cheng Z, Chen Y, Lv C, Ma L Infect Dis Poverty. 2024; 13(1):66.

PMID: 39267116 PMC: 11396325. DOI: 10.1186/s40249-024-01231-2.


Ancient DNA confirmation of lepromatous leprosy in a skeleton with concurrent osteosarcoma, excavated from the leprosarium of St. Mary Magdalen in Winchester, Hants., UK.

Cole G, Taylor G, Stewart G, Dawson-Hobbis H Eur J Clin Microbiol Infect Dis. 2022; 41(11):1295-1304.

PMID: 36114431 DOI: 10.1007/s10096-022-04494-5.


4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.

Lee J, An H, Sohn M, Kivela P, Oh S Int J Mol Sci. 2020; 21(17).

PMID: 32824985 PMC: 7503668. DOI: 10.3390/ijms21175953.

References
1.
JOLLOW D, Bradshaw T, McMillan D . Dapsone-induced hemolytic anemia. Drug Metab Rev. 1995; 27(1-2):107-24. DOI: 10.3109/03602539509029818. View

2.
Saraya M, Al-Fadhli M, Qasem J . Diabetic status of patients with leprosy in Kuwait. J Infect Public Health. 2012; 5(5):360-5. DOI: 10.1016/j.jiph.2012.08.001. View

3.
Moschioni C, Antunes C, Grossi M, Lambertucci J . Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy. Rev Soc Bras Med Trop. 2010; 43(1):19-22. DOI: 10.1590/s0037-86822010000100005. View

4.
Oleinick A . Altered immunity and cancer risk: a review of the problem and analysis of the cancer mortality experience of leprosy patients. J Natl Cancer Inst. 1969; 43(4):775-81. View

5.
Erstad B . Dapsone-induced methemoglobinemia and hemolytic anemia. Clin Pharm. 1992; 11(9):800-5. View